TACOMA, Wash., Feb. 20 /PRNewswire/ -- Northwest Kinetics, an independent Clinical Pharmacology Unit, announces the opening of its new and expanded Phase I and II research facility. Located in Tacoma, Washington, the facility incorporates functional design elements drawn from Northwest Kinetics’ 10 years of experience in conducting clinical studies, and the extensive feedback of its clients and volunteer study participants. The new facility is five times the size of the company’s previous operating space, with expanded screening and outpatient areas, overnight accommodations for 148 study participants, and increased capacity for specialized research procedures and the simultaneous conduct of multiple studies.
(Logo: http://www.newscom.com/cgi-bin/prnh/20060214/NKLOGO )
“The West Coast facility of Northwest Kinetics has provided us with industry leading clinical pharmacology services. We appreciate their continued effort to enhance their services and provide excellent attention to our needs,” said Dan Canafax, Vice President of Clinical Development for XenoPort, Inc. “We wish them well.”
“Our new facility enables us to meet the increasing demand for flexible scheduling of large, innovative early phase studies while improving our operational efficiencies,” said Jane Taylor, Chief Executive Officer. “We expect our design to support Northwest Kinetics’ leadership role in meeting clients’ changing needs as well as increasing the comfort of our volunteer study participants.”
The facility’s state-of-the-art design amplifies the company’s strength in conducting complex and procedure-intensive trials. The site efficiently accomplishes basic and specialized functions -- onsite sample processing and storage, multiple clinical pharmacology stations in large clinical procedure bays, centralized nursing stations, specialized cardiac safety systems, designated areas for microdose and mass-balance studies with radiolabeled products, technology-ready data capabilities and enhanced control of environmental conditions, safety and security. Sponsors’ monitors will enjoy private rooms, communications and business equipment support, and convenient access to the Clinical Investigators, Project Managers and other study personnel.
About Northwest Kinetics
Northwest Kinetics’ vision is to be the premier early phase clinical research partner for pharmaceutical and biotechnology companies. Located in a brand new, built-to-suit facility with 148 beds in Tacoma, Washington, we offer single-study capacity, advanced technical capability, and a full range of services for both short- and long-term Phase 0, I and II clinical studies of investigational drugs, vaccines, and devices. Founded in 1995, we are the industry leader in the western United States. For more information, please visit www.nwkinetics.com.
Photo: http://www.newscom.com/cgi-bin/prnh/20060214/NKLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comNorthwest Kinetics
CONTACT: Colleen Hoke, Director of Business Operations of NorthwestKinetics, +1-253-593-5304
Web site: http://www.nwkinetics.com/
